Suchergebnisse - "Dwyer, Amy R"

PubPharm (23)

1

Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802) : a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Palmieri, C. | Linden, H. | Birrell, S. | +12

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547897

2

The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer

enthalten in: Genome biology | 2024

von Hosseinzadeh, L. | Kikhtyak, Z. | Laven-Law, G. | +8

3

The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer

enthalten in: Genome biology | 2024

von Hosseinzadeh, L. | Kikhtyak, Z. | Laven-Law, G. | +8

4

Selective inhibition of CDK9 in triple negative breast cancer

enthalten in: Oncogene | 2024

von Mustafa, E. | Laven-Law, G. | Kikhtyak, Z. | +11

5

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

enthalten in: EMBO molecular medicine | 2023

von Prekovic, S. | Chalkiadakis, T. | Roest, M. | +22

6

Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4

enthalten in: Endocrinology | 2023

von Dwyer, A. | Perez Kerkvliet, C. | Truong, T. | +8

ErratumIn: Endocrinology. 2023 Jun 26;164(8):. - PMID 37409764

7

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

enthalten in: EMBO Molecular Medicine | 2023

von Prekovic, S. | Chalkiadakis, T. | Roest, M. | +22

8

Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer

enthalten in: British journal of cancer | 2021

von Hickey, T. | Dwyer, A. | Tilley, W.

9

High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids

enthalten in: SLAS discovery : advancing life sciences R & D | 2021

von Choo, N. | Ramm, S. | Luu, J. | +12

10

Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling

enthalten in: Molecular cancer research : MCR | 2021

von Dwyer, A. | Kerkvliet, C. | Krutilina, R. | +7